Remus Pharmaceuticals Limited
Promoter holding in Remus Pharmaceuticals Limited was 70.95% in Mar 2026. Since Mar 2023 it has risen 2.58 points.
By quarter
Quarter by quarter
| Quarter | Promoters | Public |
|---|---|---|
| Mar '26 | 70.95% | 29.05% |
| Dec '25 | No filing on record | |
| Sep '25 | 70.91%▲0.06 | 29.09%▼0.06 |
| Jun '25 | 70.85%=0.00 | 29.15%=0.00 |
| Mar '25 | 70.85% | 29.15% |
| Dec '24 | No filing on record | |
| Sep '24 | 70.84% | 29.16% |
| Jun '24 | No filing on record | |
| Mar '24 | 70.66% | 29.34% |
| Dec '23 | No filing on record | |
| Sep '23 | 69.61% | 30.39% |
| Jun '23 | No filing on record | |
| Mar '23 | 68.37% | 31.63% |
Trend
- Of the last 2 quarterly changes on record, promoter holding rose in 1 and stayed the same in 1.
- The largest quarterly change was a rise of 0.06 points in the quarter to Sep 2025.
Compared with similar companies
Promoter holding in Remus Pharmaceuticals Limited is higher than 77% of companies in India.
Questions
What is Remus Pharmaceuticals Limited's promoter holding?
Promoters held 70.95% of Remus Pharmaceuticals Limited as of 31 Mar 2026, and the public held 29.05%.
Are any promoter shares of Remus Pharmaceuticals Limited pledged?
No promoter shares are recorded as pledged.
How does Remus Pharmaceuticals Limited's promoter holding compare with similar companies?
Promoter holding in Remus Pharmaceuticals Limited is higher than 77% of companies in India. A higher or lower promoter holding is not good or bad by itself.
From the company's quarterly shareholding filings. "Public" includes institutions (foreign and domestic) and individual investors; a split by investor type is planned. ▲/▼ shows the change from the previous quarter, in percentage points. PositoAI is for research and education only and is not investment advice.